170 related articles for article (PubMed ID: 18218578)
41. Impact of separating drug prescribing and dispensing on provider behaviour: Taiwan's experience.
Chou YJ; Yip WC; Lee CH; Huang N; Sun YP; Chang HJ
Health Policy Plan; 2003 Sep; 18(3):316-29. PubMed ID: 12917273
[TBL] [Abstract][Full Text] [Related]
42. Cost per QALY (quality-adjusted life year) and lifetime cost of prolonged mechanical ventilation in Taiwan.
Hung MC; Lu HM; Chen L; Lin MS; Chen CR; Yu CJ; Wang JD
PLoS One; 2012; 7(9):e44043. PubMed ID: 22970160
[TBL] [Abstract][Full Text] [Related]
43. Health care utilization and expenditures of persons with diabetes comorbid with anxiety disorder: a national population-based cohort study.
Huang CJ; Chiu HC; Hsieh HM; Yen JY; Lee MH; Chang KP; Li CY; Lin CH
Gen Hosp Psychiatry; 2015; 37(4):299-304. PubMed ID: 25936674
[TBL] [Abstract][Full Text] [Related]
44. The cost of schizophrenia treatment in Taiwan.
Lang HC; Su TP
Psychiatr Serv; 2004 Aug; 55(8):928-30. PubMed ID: 15292543
[TBL] [Abstract][Full Text] [Related]
45. A 10-year experience with universal health insurance in Taiwan: measuring changes in health and health disparity.
Wen CP; Tsai SP; Chung WS
Ann Intern Med; 2008 Feb; 148(4):258-67. PubMed ID: 18283203
[TBL] [Abstract][Full Text] [Related]
46. Cost-effectiveness evaluation of mammography screening program in Taiwan: Adjusting different distributions of age and calendar year for real world data.
Lin CN; Lee KT; Chang SM; Wang JD
J Formos Med Assoc; 2022 Mar; 121(3):633-642. PubMed ID: 34246512
[TBL] [Abstract][Full Text] [Related]
47. Longitudinal trends in use and costs of targeted therapies for common cancers in Taiwan: a retrospective observational study.
Hsu JC; Lu CY
BMJ Open; 2016 Jun; 6(6):e011322. PubMed ID: 27266775
[TBL] [Abstract][Full Text] [Related]
48. Epidemiological features of biliary atresia in Taiwan, a national study 1996-2003.
Tiao MM; Tsai SS; Kuo HW; Chen CL; Yang CY
J Gastroenterol Hepatol; 2008 Jan; 23(1):62-6. PubMed ID: 17725591
[TBL] [Abstract][Full Text] [Related]
49. Comparison of alternative risk adjustment measures for predictive modeling: high risk patient case finding using Taiwan's National Health Insurance claims.
Chang HY; Lee WC; Weiner JP
BMC Health Serv Res; 2010 Dec; 10():343. PubMed ID: 21172009
[TBL] [Abstract][Full Text] [Related]
50. [Evaluation of health expenditures in the first 6 months after the diagnosis of cancer using a population register].
Belon-Leneutre M; Schraub S; Mercier M; Bourgeois P; Breton C
Rev Epidemiol Sante Publique; 1988; 36(4-5):318-24. PubMed ID: 3146113
[TBL] [Abstract][Full Text] [Related]
51. Out-of-pocket payment for medical care under Taiwan's National Health Insurance system.
Chi C; Lee JL; Tsai SL; Chen WY
Health Econ; 2008 Aug; 17(8):961-75. PubMed ID: 18004793
[TBL] [Abstract][Full Text] [Related]
52. Accountability, utilization and providers for diabetes management in Taiwan, 2000-2009: an analysis of the National Health Insurance database.
Chang TJ; Jiang YD; Chang CH; Chung CH; Yu NC; Chuang LM
J Formos Med Assoc; 2012 Nov; 111(11):605-16. PubMed ID: 23217596
[TBL] [Abstract][Full Text] [Related]
53. Does universal health insurance make health care unaffordable? Lessons from Taiwan.
Lu JF; Hsiao WC
Health Aff (Millwood); 2003; 22(3):77-88. PubMed ID: 12757274
[TBL] [Abstract][Full Text] [Related]
54. Development of a risk-adjusted capitation model based on principal inpatient diagnoses in Taiwan.
Lin W; Chang RE; Hsieh CJ; Yaung CL; Chiang TL
J Formos Med Assoc; 2003 Sep; 102(9):637-43. PubMed ID: 14625609
[TBL] [Abstract][Full Text] [Related]
55. Medical services utilization and expenditure of obesity-related disorders in Taiwanese adults.
Chu NF; Wang SC; Chang HY; Wu DM
Value Health; 2010; 13(6):829-36. PubMed ID: 20825625
[TBL] [Abstract][Full Text] [Related]
56. Pricing-out effect from possible user-fee policies under Taiwan's National Health Insurance.
Chen WY; Liang YW; Lin YH
Expert Rev Pharmacoecon Outcomes Res; 2010 Aug; 10(4):453-64. PubMed ID: 20715921
[TBL] [Abstract][Full Text] [Related]
57. Growing concerns and controversies to Taiwan's National Health Insurance-what are the lessons from mainland China, South Korea and Singapore?
Lee YH; Ang TFA; Chiang TC; Kaplan WA
Int J Health Plann Manage; 2018 Jan; 33(1):e357-e366. PubMed ID: 27723118
[TBL] [Abstract][Full Text] [Related]
58. QALYs and medical costs saved from prevention of a cancer: Analysis of nation-wide real-world data of Taiwan with lifetime horizon.
Lai WW; Chung CH; Lin CN; Yang SC; Hwang JS; Wang JD
J Formos Med Assoc; 2021 Dec; 120(12):2089-2099. PubMed ID: 34020855
[TBL] [Abstract][Full Text] [Related]
59. National Health Insurance program and life satisfaction of the elderly.
Liao PA; Chang HH; Sun LC
Aging Ment Health; 2012; 16(8):983-92. PubMed ID: 22681404
[TBL] [Abstract][Full Text] [Related]
60. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population.
Tscheulin DK; Drevs F
Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
